PCM TRIALS - Quality Mobile Research的动态

If you missed my presentation at SCOPE, you can catch an adapted version at the 8th Annual DCT conference here in Philly in May!

?? Exploring the Power of Network Meta-Analysis in Clinical Decision-Making ?? In the world of clinical research, making informed decisions is crucial. Network meta-analysis (NMA) has emerged as a powerful tool for comparing multiple treatments simultaneously, even when direct studies between them are lacking. This approach allows for the integration of diverse clinical trial data, providing a more comprehensive and robust view of the efficacy and safety of interventions. As a result, healthcare professionals can offer their patients options based on the best available evidence. ?? Key Points of Network Meta-Analysis: -Indirect and Direct Comparisons: It combines data to enable comparisons between treatments that haven't been evaluated together in a single study. -Treatment Ranking: Identifies which treatments are most effective based on combined evidence. -Informed Decision-Making: Improves accuracy in treatment selection by considering all possible options. ?? Our team is working to enhance the quality of evidence and support healthcare professionals in making more accurate clinical decisions. ?? Salvador Pastor-Idoate IOBA UVa #Healthcare #ClinicalResearch #NetworkMetaAnalysis #DataDrivenEvidence #InformedDecisions

Catch up on #healthtech news from around the world: - Digital Health Cooperative Research Centre announces the launch of a new collaboration on digital tech, informatics and data science in Australia - update on the remote monitoring work at Children’s Hospital of Philadelphia - Croatian Ministry of Health announces installation of the first linear accelerator (cancer treatment device) of 21, to be provided for citizens under the National Recovery and Resilience Plan Plus interviews from New Zealand, Spain, Canada, Portugal, the USA and more. Keep up-to-date with what's happening in #digitalhealthcare on an international level: https://htn.international

??♀? October has been a whirlwind of activity at IHI Towers! Here’s our round-up of the biggest news stories from the month…. ?????? ???????? ? The top news is the publication of the draft topic texts of IHI call 9 (single-stage, applicant-driven) and IHI call 10 (two-stage, with topics on #DigitalLabelling #EHDS and #PFAS)?https://europa.eu/!8d3rF8 ?? Meanwhile we’re counting down to our Brokerage Event on call 9 in Brussels on 12-13 November. There’s still time to register!?https://europa.eu/!CfF6rp ?????? ?????? ???????????????? ?? We welcomed 5 new projects to the IHI family! IHI ILLUMINATE project Accelerate.EU and Thera4Care will tackle #theranostics, while UMBRELLA_IHI focuses on #stroke and Synthetic hEalthcare dAta goveRnanCe Hub addresses the need for #SyntheticData. Give them a follow to stay updated on their activities! ?????????????????? ???????? ?????? ???????????????? ?? Check out the H2O Insights Centre - an easy-to-use online tool for visualising aggregated population level #HealthData for patients within the H2O ecosystem https://lnkd.in/eVQDuWeG? ??? The GetReal Institute has released a refreshed version of the Real-World Evidence Navigator (https://lnkd.in/guKn9-fU) that was originally developed during the IMI GetReal Project. ?? A new #RSV challenge agent is being manufactured as part of #Inno4Vac for use in strictly controlled clinical trials where volunteers are given a carefully considered dose of a pathogen to test a #vaccine or treatment. https://lnkd.in/e7F4A-Ri ???????????????????????? ???????? ?????? ???????????????? ?? An IMI_SOPHIA paper in Nature Medicine describes a powerful algorithm that leverages heterogeneity in #obesity for the prediction of #cardiovascular (and other) diseases https://rdcu.be/dXXoI ???? Immune-Image celebrates the publication of the first paper with a tracer newly developed in the project. The work could improve the effectiveness and safety of #immunotherapies https://lnkd.in/e7GSt9Zh ?? IMI ConcePTION published a systematic review of #gabapentinoid use during #pregnancy and its impact on pregnancy and childhood outcomes https://lnkd.in/dhC2Td9F? ?? OPTIMA Oncology’s study of #LungCancer trends in the UK contributes significantly to our understanding of population health and cancer survival https://buff.ly/48iLdbk ?? VALUE-Dx’s paper identifies key factors that influence the use of point-of-care tests (POCTs) for managing respiratory #infections in primary care https://bit.ly/3NJOM0J? ?? NECESSITY Project developed a web-based tool to help assess fluctuations in the intensity of #Sj?gren's disease symptoms https://lnkd.in/ehRVWBP4 ?????? ??????????????... ?? Watch this video from #Mobility project Mobilise-D including some fun behind-the-scenes moments! https://lnkd.in/gWGBmFUW #HorizonEU #IHITransformingHealth?

Are you curious about how data is gathered in clinical trials, including decentralized trials? At CliniLink Health, our process begins when patients and volunteers opt to participate in our studies. We meticulously collect and analyze data from their enrollment through every trial phase. At CliniLink Health, our detailed approach involves gathering data at various stages, from target and recruiting phases to pre-marketing, and through patient engagement during trials. This data is not just crucial, it's the lifeblood of our research. It's what allows us to pinpoint areas of focus for sponsors, such as understanding why Site A experiences more dropouts compared to Site B, despite being in the same geographic area. Join CliniLink Health and contribute to groundbreaking medical research. Your participation drives scientific advancements and shapes the future of healthcare. Be a catalyst for change! Visit https://lnkd.in/eSG9eYRa to discover more about our initiatives. #clinilinkhealth #CliniLink #clinicaltrials #HealthcareResearch #clinicalresearch #DataCollection #HealthcareInnovation #InclusivityMatters

Terrific analysis and recommendations here -- excited to see how the ARPA-H Advancing Clinical Trial Readiness project and ARPANET-H will drive innovation, attract further investment, and help raise these scores #clinicalresearch #clinicaltrials #equitymatters

Are decentralised trials the solution to our clinical trial woes? From improving participant experience to enhancing diversity, decentralised trials (DCTs) offer exciting possibilities. But are they the solution we've been waiting for? We take a look in our latest article, where we explore the benefits and challenges of decentralised trials, and what they mean for the future of clinical research. Read more here: https://lnkd.in/eA3ZVKRZ To watch our recent webinar on this topic, click here: https://lnkd.in/eZcnqN62 #ClinicalTrials #DecentralisedTrials #HealthcareInnovation

#DTx clinical trials offer a wide range of solutions to create more patient-centric research experiences. Decentralized clinical trial (DCT) models set a new standard for this as well as trial efficiency and inclusivity. Anthony B., Director of Clinical Operations here at Lindus Health, talks about just this in his latest article featured in the ACRP - Association of Clinical Research Professionals, highlighting real data from study participants regarding engagement in clinical research. Read the full article here: https://lnkd.in/eBnTM7iM #opinion #digitaltherapeutics #clinicaltrials #DCT

Are you curious about how data is gathered in clinical trials, including decentralized trials? At CliniLink Health, our process begins when patients and volunteers opt to participate in our studies. We meticulously collect and analyze data from their enrollment through every trial phase. At CliniLink Health, our detailed approach involves gathering data at various stages, from target and recruiting phases to pre-marketing, and through patient engagement during trials. This data is not just crucial, it's the lifeblood of our research. It's what allows us to pinpoint areas of focus for sponsors, such as understanding why Site A experiences more dropouts compared to Site B, despite being in the same geographic area. Join CliniLink Health and contribute to groundbreaking medical research. Your participation drives scientific advancements and shapes the future of healthcare. Be a catalyst for change! Visit https://lnkd.in/eyxKjPbg to discover more about our initiatives. #clinilinkhealth #CliniLink #clinicaltrials #HealthcareResearch #clinicalresearch #DataCollection #HealthcareInnovation #InclusivityMatters

#DIAEurope2025 is must have for pharmaceutical, drug development & clinical trials industry ?? In addition, this year the conference was designated as a "Patients included" meeting: https://bit.ly/3LmbH19